It will now be easier for New Brunswickers to access a pill to treat COVID-19.
The province is expanding access to Paxlovid, the first oral antiviral treatment for COVID-19 patients which was approved by Health Canada in January.
The Department of Health says treatments are being expanded to include anyone who has recently tested positive, those experiencing mild to moderate symptoms and those who are most at risk such as seniors and the immunocompromised.
The change is intended to make it easier for eligible patients to access this option.
Pharmacists can now do assessments and prescribe the drug.
Previously, New Brunswickers had to see a doctor or nurse practitioner within five days of the onset of symptoms to become eligible for the pill.
The change follows a collaboration with the New Brunswick College of Pharmacists and the New Brunswick Pharmacists’ Association to establish a new assessment and prescribing option for the treatment.
A list of participating pharmacies can be found HERE.
Comments